Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Number of Operating Segments

2.8 / 5 stars · 68/120 Roast Me

LEXICON PHARMACEUTICALS, INC. Number of Operating Segments

LEXICON PHARMACEUTICALS, INC. (LXRX) reported Number of Operating Segments of 1 segment for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfOperatingSegments · last filed 2026-03-05

  • LEXICON PHARMACEUTICALS, INC. number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
  • LEXICON PHARMACEUTICALS, INC. number of operating segments for fiscal 2024 was 1.00 segment, a 0.00% change from fiscal 2023.
  • LEXICON PHARMACEUTICALS, INC. number of operating segments for fiscal 2023 was 1.00 segment, a 0.00% change from fiscal 2022.
  • LEXICON PHARMACEUTICALS, INC. number of operating segments for fiscal 2022 was 1.00 segment, a 0.00% change from fiscal 2021.
Period endNumber of Operating Segments 12 month
2025-12-311.00 segment
10-K · filed 2026-03-05
2024-12-311.00 segment
10-K · filed 2025-03-07
2023-12-311.00 segment
10-K · filed 2024-03-25
2022-12-311.00 segment
10-K · filed 2023-03-03
2021-12-311.00 segment
10-K · filed 2022-03-10
2020-12-311.00 segment
10-K · filed 2021-03-12
2019-12-311.00 segment
10-K · filed 2020-03-12
2018-12-311.00 segment
10-K · filed 2019-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78